Jennie Lee

Jennie Lee has a diverse and extensive work experience in the pharmaceutical and biotechnology industry. Jennie is currently the Associate Director of Analytical Development and Quality Control at Leap Therapeutics, a position they have held since August 2023. Prior to this, they worked as the Sr Manager of Analytical Development and Quality Control at Leap Therapeutics from May 2021 to October 2023.

Before joining Leap Therapeutics, Jennie worked at Sanofi as the QC Manager - QA Technical Services from January 2020 to May 2021. Prior to that, they were employed at Moderna as a Senior QC Specialist for Analytical Method Transfers from February 2019 to January 2020.

Jennie also gained valuable experience at Brammer Bio as a Senior Scientist in Analytical QC from September 2018 to February 2019.

Their extensive career in the biotechnology industry also includes various roles at Genzyme Corp, where they served as a Principal QC Analyst for Methods Validation from March 2017 to September 2018, a Senior QC Analyst for Methods Validation from October 2013 to March 2017, a Senior QC Analyst for Operations from September 2009 to September 2013, and a QC Analyst II from February 2006 to September 2009.

Jennie's career started at Life Technologies, where they worked as a Senior Inspector from an unspecified date in 2000 until 2006.

Overall, Jennie Lee's career demonstrates a strong background in analytical development, quality control, and method validation within the pharmaceutical and biotechnology industry.

Jennie Lee attended Boston University and obtained a Bachelor of Science degree in Biochemistry and Molecular Biology. No further information is available regarding specific years of enrollment or any additional degrees earned.